Close
Back to mobile site

Regeneron Pharma (REGN) PT Lowered to $344 at BMO Capital

August 7, 2019 8:14 AM EDT Send to a Friend
BMO Capital analyst Brian Skorney ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login